The global automotive gears market is projected to reach 50.8 billion in 2030, projected to grow at a CAGR of 3.0% in the forecasted period. The major players in the automotive gears industry include American Axle & Manufacturing Holding, Inc. (US), GKN Powder Metallurgy (US), Bharat Gears Ltd. (India), JTEKT Corporation (Japan), and Robert Bosch GmbH (Germany).
The global market for the IT operations analytics market is projected to reach USD 127.4 billion in 2029, at a CAGR of 36.6% during the forecast period. The major IT operations analytics solutions and service providers include Cisco (US), Broadcom (US), IBM (US), Oracle (US), Microsoft (US), OpenText (Canada), Hitachi (Japan), Dynatrace (US), SolarWinds (US), BMC Software (US), NetApp (US), Elastic (US), Nexthink (Switzerland), HCL Technologies (India), New Relic (US), ServiceNow (US), Dell Technologies (US), HPE (US), Cloud Software Group (US), Veritas Technologies (US), BigPanda (US), ExtraHop Networks (US), Squadcast (US), ScienceLogic (US), Apica (Sweden), Diamanti (US), MCG (Denmark), Evolven (US), XPLG (US), HEAL Software (US), Sumo Logic (US), Devo (US), meshIQ (US), and CloudFabrix (US). These companies have used both organic and inorganic growth strategies such as product launches, acquisitions, and partnerships to strengthen their position in the IT operations analytics market.
The human microbiome market is expected to grow from USD 814.6 million in 2024 to USD 4,206.0 million in 2030, at a CAGR of 31.5% during the forecast period. Key players in the Human Microbiome market are Nestle S.A. (Switzerland), Ferring Pharmaceuticals (Switzerland), BiomeBank (Australia), Seed Health, Inc. (US), International Flavors & Fragrances Inc (US), Pendulum (US), BioHM Health Inc. (US), Actial Farmaceutica SRL (Italy), Optibiotix Health plc (UK), Resbiotic (US), Infinant Health Inc (US), Biogaia AB (Sweden), and Exegi Pharma Llc (US).
The pharmaceutical drug delivery market is expected to grow from USD 1,949.4 billion in 2024 to USD 2,546.0 billion by 2029, at a CAGR of 5.5% during the forecast period. As of 2023, pharmaceutical drug delivery in was dominated by Johnson & Johnson services, inc (US) , Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US) , Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Sanofi (France), Bayer AG (Germany), among others
The polymethyl methacrylate (PMMA) market is expected to grow from USD 5.1 billion in 2024 to USD 6.1 billion by 2029, at a CAGR of 3.4% during the forecast period. Trinseo S.A. (US), SABIC (Saudi Arabia), Rohm GmbH (Germany), Asahi Kasei Corporation (Japan), Mitsubishi Chemical Group Corporation (Japan), LX MMA (South Korea), and CHIMEI Corporation (Taiwan).are the key players operating in the PMMA market. Expansions, acquisitions, and deals are some of the major strategies adopted by these key players to enhance their positions in the Polymethyl Methacrylate (PMMA) market.
The needle holder market is expected to grow from USD 367.3 million in 2024 to USD 530.3 million by 2029, driven by increased healthcare investments, a rise in surgeries, and the adoption of microsurgery and outpatient procedures. Key challenges include high surgery costs and competition from alternative techniques like robotic-assisted surgeries. North America leads the market, with major players including B. Braun, Olympus, and Karl Storz.
The AI agents market is projected to reach USD 47.1 billion by 2030. This notable expansion, characterized by a robust CAGR of 44.8% during the forecast period. The major players in the AI agents market include Google (US), Amelia (US), IBM (US), OpenAI (US), and AWS (US) along with SMEs and startups such as Fluid AI (India), Stability AI (UK), Cognigy (Germany), Aisera (US), and Cognosys (Canada).
The antiscalants market is expected to grow from USD 4.5 billion in 2024 to USD 5.9 billion by 2029, at a CAGR of 5.4% during the forecast period. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the antiscalants market. These are Dow (US), BASF SE (Germany), Ecolab (US), Solenis (US), Kemira (Finland), Kurita Water Industries Ltd. (Japan), Syensqo (Belgium), Clariant (Switzerland), Veolia (France), Italmatch Chemicals S.p.A (Italy).
The vascular stents market is set to grow from USD 11.4 billion in 2024 to USD 15.6 billion by 2029, fueled by increasing vascular diseases and a shift towards minimally invasive procedures. Growth is driven by demand for advanced stents, including bioresorbable types, though regulatory hurdles and product recalls pose challenges. North America leads the market, with hospitals as key end-users. Major players include Medtronic, Abbott, and Boston Scientific, with recent advancements focusing on drug-eluting and bioresorbable stents.
The behavior analytics market is projected to reach 13.4 billion by 2029 at a CAGR of 19.5% during the forecast period. The major vendors covered in the behavior analytics market are Qualtrics (US), OpenText (Canada), Microsoft. (US), Cisco Systems, Inc. (US), IBM (US), Zoho Corporation (India), Oracle (US), Varonis Systems, Inc. (US), Fortinet, Inc. (US), Securonix (US), Teradata (US), Google (US), Adobe (US), SAS Institute (US), Qlik (US), 84.51° (US), Contentsquare (France), Exabeam (US), Clevertap (US), Dtex Systems (US), Mouseflow (US), Gurucul (US), Netspring (US), Visier, Inc. (Canada), Teramind (US), SplashBI (US), Amplitude (US), Prohance (India). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the behavior analytics market.
The natural dyes market is expected to grow from USD 4.8 Billion in 2024 to USD 6.4 Billion by 2029, at a CAGR of 5.7% during the forecast period. Acquisitions, new product launches, expansion and partnerships are the major growth strategies adopted by the key players in the market. The key global players in the natural dyes market include Abbey Color (US), AMA Herbal (India), Pylam Products Company Inc. (US), Archroma (Switzerland), GNT Group (Netherlands), Stony Creek Colors (US), NIG GmbH (Germany), Givaudan (Switzerland), Dohler GmbH (Germany), and Couleurs DE Plantes (France)
The urban air mobility market is expected to grow from USD 23.5 billion by 2030 to USD 41.5 billion in 2035, at a compound annual growth rate (CAGR) of 12.1% during the forecast period.The key players Lilium Aviation Gmbh (Germany), Archer Aviation Inc. (US), Eve Holdings, Inc. (Brazil), Airbus (France), and Ehang (China).
The global hydrogen truck market is projected to reach USD 10.8 billion by 2035 at a CAGR of 16.9% during the forecast period. The major players in the hydrogen bus and truck market include Foton International (China), Yutong Bus Co., Ltd. (China), Xiamen King Long International Trading Co., Ltd. (China), Solaris Bus & Coach sp. z o.o. (Poland), and Hyundai Motor Company (South Korea). These companies offer hydrogen buses and trucks and have strong global distribution networks and are focussing on developing long-range vehicles. For instance, in May 2023, Hyundai Motor launched the commercialized XCIENT Fuel Cell tractor for the North American market at the ACT Expo.
The global security testing market size is projected to reach USD 43.9 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 24.7% during the forecast period. The key players in the Security Testing market are IBM (US), HCLTech (India), Synopsys (US), OpenText (UK), Cigniti (US), Qualitest (UK), Intertek (UK), DXC Technology (US), eInfochips (US), Checkmarx (US), HackerOne (US), Invicti (US), DataArt (US), Cobalt Labs (US), Trustwave (US), Contrast Security (US), Veracode (US), Qualys (US), OffSec (US), NCC Group (UK), GitHub (US), Bugcrowd (US), Applause (US), Rapid7 (US), Parasoft (US) and others.
The cell-based assays market is set to expand from USD 17.3 billion in 2024 to USD 24.3 billion by 2029, growing at a CAGR of 7.1%. This growth is driven by increasing demand for drug discovery and development, supportive government funding, and a shift towards cell-based assays over animal testing. The market benefits from rising cancer prevalence and expanding applications in chronic diseases and personalized medicine. However, high instrument costs and regulatory restrictions on reagents may hinder growth. Key segments include consumables, drug discovery applications (especially toxicity studies), and a strong focus on North America. Advances in assay technologies and strategic partnerships among major players are expected to further boost the market.